Tech Company Financing Transactions

Outpost Bio Funding Round

On 3/2/2026, Outpost Bio secured $3.5 million in Seed financing from Merantix, Seedcamp and Defined Capital.

Transaction Overview

Company Name
Announced On
3/2/2026
Transaction Type
Venture Equity
Amount
$3,500,000
Round
Seed
Investors

Merantix (Lead Investor)

Seedcamp (Lead Investor)

Defined Capital

Proceeds Purpose
The company intends to use the funds to advance its experimental and modeling infrastructure.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
27 Courtney Road
London, N7 7BQ
UK
Phone
Undisclosed
Email Address
Not Recorded
Overview
Our mission is ambitious, and our standards are high. Our culture is built on intellectual honesty, deep ownership, reliably doing what we say we will do. If you are a builder who thrives on candid feedback and are ready to do the best work of your career, we would love to meet you. We're building AI to predict how interventions impact the human microbiome and will be contributing foundational datasets and models back to the scientific community. We're seeking collaborators with rich pre/post-intervention datasets of the microbiome. We'll offer partners rich insights to existing datasets.
Profile
Outpost Bio LinkedIn Company Profile
Social Media
Outpost Bio Company Twitter Account
Company News
Outpost Bio News
Facebook
Outpost Bio on Facebook
YouTube
Outpost Bio on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jenny Yang
  Jenny Yang LinkedIn Profile  Jenny Yang Twitter Account  Jenny Yang News  Jenny Yang on Facebook
Chief Operating Officer
Alex Merwin
  Alex Merwin LinkedIn Profile  Alex Merwin Twitter Account  Alex Merwin News  Alex Merwin on Facebook
VP - Engineering
Saif Ur-Rehman
  Saif Ur-Rehman LinkedIn Profile  Saif Ur-Rehman Twitter Account  Saif Ur-Rehman News  Saif Ur-Rehman on Facebook
VP - R & D
Heidi arjes
  Heidi arjes LinkedIn Profile  Heidi arjes Twitter Account  Heidi arjes News  Heidi arjes on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/2/2026: Egle Therapeutics venture capital transaction
Next: 3/2/2026: Akave venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary